In conclusion, our study demonstrated that circARID1A promoted GBM migration and invasion by modulating the miR-370-3p/ TGFBR2 pathway, and may serve as a potential serum biomarker of GBM. The gene discussed is TGFBR2; the disease is glioblastoma.